| Date | Title | Description |
| 17.12.2025 | CRISPR Biosensors Transform Real-Time Health Monitoring With Cutting-Edge Biotech Innovation | By Glanze Patrick
Published: Dec 17 2025, 06:02 AM EST
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 15.01.2025 | UK set for AI tech boost as millions of pounds injected after action plan | - |
| 06.06.2024 | The Role of Science-Driven Alt Protein Startups in Addressing Global Food Security | A recent review article published in Nature Communications explored an ecosystem of alternative protein startups and their science-powered innovations, exploring the potential market penetration of products and their impact on addressing th... |
| 29.05.2024 | HuidaGene and Synthego Announce Licensing Agreement on Next-Generation Gene Editing Enzyme, hfCas12Max | SHANGHAI and REDWOOD CITY, Calif. , May 29, 2024 /PRNewswire/ -- HuidaGene Therapeutics ("HuidaGene"), a global clinical-stage biotechnology company focused on advancing CRISPR-based genomic medicines, and Synthego Corporation (&q... |
| 01.04.2024 | Впервые в мире почку свиньи изменили генетически и пересадили человеку. Теперь их можно массово пересаживать... | Хирурги из США провели человеку трансплантацию почки, полученной из генетически модифицированной свиньи. СМИ сообщают, что данная операция является прорывом в области ксенотрансплантации, когда органы, клетки или ткани пересаживаются из одн... |
| 21.12.2023 | CRISPR, генная и клеточная терапия: краткая история прорывных технологий | Многие заболевания и серьезные нарушения можно исправить, если вмешаться в генетический код человека. Это и генетические заболевания, включая врожденные пороки, слепоту и т. д, и последствия мутации клеток, такие как онкология, и даже лечен... |
| 18.05.2023 | Discover-Seq+ | Технология CRISPR/Cas9 произвела революцию в геномном редактировании: в 2020 году за нее вручили Нобелевскую премию, а сегодня FDA уже готовится одобрить первую CRISPR-генную терапию для лечения гемоглобинопатий. Однако основной принцип сис... |
| 07.04.2023 | Synthego Launches Express Cell Pools for Faster, More Efficient Genome Editing | Synthego Corp., a leading provider of genome engineering solutions, has announced the launch of Express Knockout Cell Pools, a new product offering that revolutionizes access to CRISPR-mediated gene editing by providing researchers access t... |
| 27.02.2023 | Synthego has started using Xavo's Cloud-Based Sample Management System productively for their Engineered Cells Factory | Xavo, a leading provider of Software-as-a-Service for Biopharma R&D is pleased to announce that Synthego has gone live with Xavo R3.
BOSTON, MA, USA, February 27, 2023 /EINPresswire.com/ -- Xavo, a leading provider of Software-as-a-Serv... |
| 10.05.2022 | Pow.bio’s continuous fermentation technology might be the key to scaling up food production for a growing population | Fermentation, the process of breaking down sugars using the enzymes of microorganisms, is almost as old as civilization itself. The use of microbial cultures to preserve and improve the nutritional value of foods and produce alcoholic bever... |
| 18.02.2022 | Synthego lands $200M | Synthego has raised $200 million in a round led by Perceptive Advisors. The company is the developer of a genome engineering platform to help discover new therapies. Synthego was valued at $450 million in 2020, according to PitchBook data.
... |
| 17.02.2022 | With $200M in new cash, Synthego wants to become the manufacturing bedrock for CRISPR. But where are its customers? | After nearly a decade developing CRISPR-based tools to help researchers in academia and biotech run their experiments, Synthego is getting into a new game: manufacturing.
The startup, founded by two brothers with engineering experience but ... |
| 22.07.2021 | The Association of American Physicians and Surgeons (AAPS) Asks: How Do We Know the Effects of the Genetic Technology behind COVID Vaccines? | TUCSON, Ariz., July 22, 2021 (GLOBE NEWSWIRE) -- A major reason for vaccine hesitancy is the belief that the COVID jabs might alter your genes. A recent article in Medscape addresses this concern: “Chance That COVID-19 Vaccines Are Gene The... |
| 27.08.2020 | Synthego Raises $100M in Series D Funding | Synthego, a Redwood City, Calif.-based genome engineering company, raised $100m in Series D financing.
The round was led by new investor Wellington Management, co-led by RA Capital Management and 8VC. Additional investors included Founders ... |
| 27.08.2020 | Synthego Pulls In $100M Series D Financing |
REDWOOD CITY, CA, Synthego, the genome engineering company, today announced that it raised $100 million in a Series D financing.
>> Click here for more funding data on Synthego
>> To export Synthego funding data to PDF and E... |
| 26.08.2020 | Synthego raises $100 million for AI-driven gene editing | Synthego, which is developing a machine learning-based approach to engineering genomes, today closed a $100 million funding round. The startup says the funding will be put toward expanding the capabilities of its platforms designed to produ... |
| 26.08.2020 | Synthego : Raises $100 Million to Accelerate CRISPR Platform Scale-up in Response to Growing Demand | REDWOOD CITY, Calif., Aug. 26, 2020 /PRNewswire/ -- Synthego, the genome engineering company, today announced that it raised $100 million in a Series D financing led by new investor Wellington Management, co-led by RA Capital Management and... |
| 26.08.2020 | Synthego raises $100 million for AI-driven gene editing | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
Synthego, which is developing a machine learning-... |
| 26.08.2020 | Synthego Raises $100 Million to Accelerate CRISPR Platform Scale-up in Response to Growing Demand | |
| 26.03.2020 | What it’s like to go into the lab at a biopharma company during the coronavirus pandemic | Like grocery store clerks and Amazon delivery drivers, they’re among the essential workers of the coronavirus pandemic: the biopharma employees who must still go in to the lab or the manufacturing plant. But for these employees, going to wo... |
| 09.03.2020 | CRISPR: Its Potential And Concerns In The Genetic Engineering Field | Photo:Getty |
| 23.10.2018 | Synthego raises $110 million to make gene editing technologies more accessible | Paul Dabrowski, the chief executive officer of Synthego, which provides genetically engineered cells to scientists and researchers, worries about a future where access to the genetic technologies that will reshape the world are only availab... |
| 23.10.2018 | Peter Thiel’s Founders Fund leads $110 million investment in genetic engineering startup Synthego | Genome engineering company Synthego has raised $110 million in a series C round of funding led by Peter Thiel’s Founders Fund, with participation from 8VC and Menlo Ventures.
Founded in 2012 by brothers and former SpaceX design and engineer... |
| 23.10.2018 | Synthego Nabs $110M |
REDWOOD CITY, CA, Synthego, a leading genome engineering innovation company, today announced a $110 million Series C financing round.
>> Click here for more funding data on Synthego
>> To export Synthego funding data to PDF ... |
| 23.10.2018 | CRISPR toolmaker Synthego raises $110M Series C led by Peter Thiel’s VC fund | Founders Fund also led the company’s Series A funding round, COO Ted Tisch noted in a phone interview. That round, closed in 2013, totaled $8.3 million and also saw participation from Menlo Ventures and WI Harper Group, according to Crunchb... |
| 23.10.2018 | Synthego Raises $110M in Series C financing | Synthego, a Redwood City, CA-based genome engineering innovation company, raised $110m in Series C financing.
The round, which brings total funding to $160m, was led by Founders Fund with participation from existing investors 8VC and Menlo ... |
| 23.10.2018 | Peter Thiel’s Founders Fund leads $110 million investment in genetic engineering startup Synthego | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
Genome engineering company Synthego has raised $1... |
| 06.06.2018 | Synthego’s new products give scientists access to edited genetic material | Synthego, a provider of gene editing services for genomics research and experimentation, has launched a new suite of products that give researchers access to edited genetic material to make experimenting with programmable biology easier.
Th... |
| 23.04.2018 | 8VC has closed its second early-stage fund, seemingly with an eye on logistics and biotech | 8VC, the early-stage, San Francisco-based venture firm founded in 2015 by serial entrepreneur Joe Lonsdale and four other general partners, has closed it second early-stage venture fund with $640 million in commitments, says one of its inve... |
| 26.10.2017 | Term Sheet — Thursday, October 26 | DATA CRAZE
Good morning, Term Sheet readers.
Paid Content What you need to know about growing cyberattacks From ExtraHop
On Wednesday, the firm announced an operating system for early-stage investing called “capital-as-a-service.” Put simpl... |
| 20.10.2017 | Synthego Receives Investment from Intel Capital | Synthego, a Redwood City, CA-based provider of genome engineering solutions, received an investment of undisclosed amount from Intel Capital.
The company intends to use the funds for the advancement of bioinformatics tools and technologies.... |
| 19.10.2017 | Data is the name of the game, as Intel Capital puts $60M in 15 startups, $566M in 2017 overall | Intel Capital, the investment arm of the processor giant, is today announcing its latest tranche of investments, a total of nearly $60 million going in to 15 startups that are working on solving different problems in the bigger area of big ... |
| 04.01.2017 | Term Sheet — Wednesday, January 4 | DELL-EMC, NYC EXITS, HYPEMOBILES
Hello from Las Vegas, where I’m riding in cars with robots and hunting down the most ridiculous “smart” items CES has to offer. (Current front-runners: a smart mattress and a smart hairbrush.)
Paid Content S... |
| 04.01.2017 | Synthego Raises $41M in Series B Financing | Synthego, a Redwood City, CA-based provider of genome engineering solutions, raised $41m in Series B financing.
The round was led by 8VC, with participation from Jerry Yang’s AME Cloud Ventures, Elements Capital, OS Fund, Alexandria Equitie... |
| 04.01.2017 | Synthego Raises $41M in Series B |
REDWOOD CITY, CA, Leading provider of genome engineering solutions, announces today a $41 million Series B financing.
>> Click here for more funding data on Synthego
>> To export Synthego funding data to PDF and Excel, click... |
| 06.03.2014 | Founders Fund has a fresh $1B to spend. Here’s a look at its healthcare picks | As of late, it’s been doing quite a bit in the digital health and genetics space. Here’s a look at the health-focused companies it’s invested in through its angel and venture funds
This list was compiled based on the fund’s website and news... |
| - | Founders Fund has a fresh $1B to spend. Here’s a look at its healthcare picks | The rumors were true – kind of: The Founders Fund has been out raising a massive amount of cash for a fifth fund, but it’s not $750 million as originally thought. It’s $1 billion, the fund said today.
Most known for backing Facebook, Spotif... |
| - | Full Stack Genome Engineering: the end-to-end solutions making CRISPR accessible to all | CRISPR is the coolest technology in a scientist’s toolbox these days because of its unique blend of being extremely powerful yet relatively simple to use. The technique relies on two basic components: a CRISPR-associated (Cas) nuclease that... |
| - | A new immunotherapy approach for efficient cancer treatment | This article is adapted from the original, which first appeared on The Bench, the Synthego blog.
The medical community has been striving for decades to develop effective treatments for treating cancer. As there are more than 100 different t... |
| - | CRISPR toolmaker Synthego raises $110M Series C led by Peter Thiel’s VC fund | A company that develops products for research in CRISPR gene editing technology has received a new round of funding led by a large Silicon Valley venture capital firm.
Synthego, based in Redwood City, California, said Tuesday that it had cl... |
